Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The lose of Brian and Wolf will hurt the value of this message board.

No, it says PDS, because that's the joint entity that is the "holding" entity for the licensing efforts. So it reads correctly. Since TPL gets money from PDS for both licensing efforts and from remaining profit distributions, and PTSC only gets it for the remaining profit distributions, TPL does benefit from the funding in a way that PTSC does not.

Share
New Message
Please login to post a reply